Finasteride after a hair transplant: do you still need medication, if the transplanted hair is less sensitive to DHT?

Hair transplantation is built on the principle of donor dominance: the transplanted strand keeps, in its new location too, the properties it carried in its original location. This is how Queen and Avram's 2025 review, which summarises the last five years of hair transplantation literature, describes it.1 The donor area is the part from which the surgeon removes the follicles. Per the Indian hair transplantation guideline (Mysore and colleagues, 2021), when a strip of skin is removed, the middle of the strip sits around the occipital protuberance, and the guideline only recommends removal from the safe donor area, because strands outside it would be lost over time.2

There's a cell-level explanation for the sensitivity of strands from the crown and hairline. Per Inui and Itami's 2011 review, in the papilla of follicles on balding scalp, the cell cluster at the base of the follicle that directs growth has more androgen receptors than on non-balding areas, and in follicles involved in male-pattern hair loss, the papilla also has more of the type II 5-alpha reductase enzyme than other parts of the body.3 This enzyme converts testosterone to DHT (dihydrotestosterone), and finasteride inhibits this enzyme; I described the tablet's details in the article on oral DHT blockers.4 These lab studies compared cells from balding and non-balding areas, not specifically the back of the head with the hairline, so they only partly explain the donor area's resistance.

Leavitt and colleagues, in their 2005 study, start from the same point: the coverage gained from a transplant can shrink if the existing, non-transplanted hair keeps thinning and falling out.5 The Indian guideline states that hair transplantation is not a one-off, permanent fix for male pattern hair loss, because the hair loss itself is ongoing,2 and a 2026 review also states that the surgery itself doesn't stop the process, so patients often need additional medical treatment. The same review states that graft survival can also be low, for example because of differences in surgical technique and extraction method, thinning of the donor area in severe hair loss, or a limited donor supply.6 What you can take from this: the surgery replaces the transplanted area, while the same process keeps acting on your own surrounding hair as it did before the surgery.

What to stop before surgery, when you can restart it, and when anything may touch the transplanted area, is set by your surgeon. The Indian guideline's pre-operative instructions state that you should follow the operating surgeon's instructions;2 it gives no rule for restarting afterwards or for the timing of devices. I'm not a doctor, I'm a cosmetology student. This article collects what the studies measured and what the recommendations say, so you know what to ask.

Leavitt and colleagues looked in 2005, in a randomised, double-blind, placebo-controlled study, at what finasteride adds alongside hair transplantation. Randomised means who went into which group was decided by a random draw; double-blind means neither the participant nor the assessor knew who was getting what. 79 men took part, aged 20 to 45, with male pattern hair loss: 40 took 1 mg finasteride once daily, 39 took a placebo, from 4 weeks before surgery to 48 weeks after.5

The effect was measured in two ways: a dermatologist expert reviewed photos of the scalp, and hairs were counted on macro-photographs. At week 48, those taking finasteride improved significantly more from baseline on both measures than those on placebo. Visible growth on the top and front of the scalp was recorded in 94% of those taking finasteride and 67% of those on placebo. According to the authors, participants generally tolerated finasteride well.5

The study aimed to look at the growth of non-transplanted hair around the transplanted area and hair on the scalp; the authors' conclusion was that finasteride improved the hair around the transplant and increased hair density. The abstract reports no data on the survival of the transplanted hairs themselves. Only men took part, and this study gives no data beyond 48 weeks. The 67% figure in the placebo group indicates that visible growth without finasteride, from the surgery alone, also occurred; this is my own reading. I only had access to the abstract of the paper, not the full text.5 What you can take from this: a single study of 79 men found that finasteride alongside a transplant improved the person's own hair; it doesn't answer the question of whether the transplanted hairs themselves survive.

The Indian guideline recommends that every patient be told why it's important to continue medical treatment after surgery too. As approved treatments for male pattern hair loss, it names 2 to 5% minoxidil applied to the scalp and 1 mg oral finasteride daily, and states that the dose and duration should be adjusted to the extent of the hair loss. It assigned this a level 1 evidence grade and a grade A recommendation.2 The rating applies to the principle of continuing treatment, not to a study done only on transplant patients.

The same guideline's pre-operative checklist states that minoxidil should be stopped one week before the procedure, because it may increase bleeding. It grades this list at evidence level 4 and grade D, a weaker rating than the one for continuing treatment. Finasteride doesn't appear on this list, and in the Leavitt study participants kept taking it during surgery too.25 The guideline doesn't state when minoxidil can be restarted.

In October 2001, 11 international hair loss and hair transplantation experts met to review the role of minoxidil alongside transplantation. Their consensus, published in 2002, states that based on surgeons' clinical experience, approved hair growth medications may increase hair density, speed up the regrowth of transplanted follicles, and slow or stop further loss in people who still have some functioning, if weak, follicles in the area to be transplanted.7 This is expert opinion, based on surgeons' clinical experience, with no controlled trial behind it. Queen and Avram's 2025 review states that careful hairline design and medication alongside surgery improved aesthetic outcomes.1 What you can take from this: the guideline recommends continuing medical treatment with a strong rating, and pausing minoxidil before surgery with a weaker one. Ask your surgeon this: when should I stop minoxidil, and from when can I use it again?

PRP is platelet-rich plasma. Sindhusen and colleagues' 2025 systematic review, meaning an analysis that methodically gathers all available studies, found three controlled studies on using PRP together with hair transplantation, with 217 participants in total: two were randomised, one wasn't. Every one of the studies linked PRP to a better outcome, for example greater hair density, better follicle survival and earlier-starting hair growth.8 PRP is made from the patient's own blood.9

The review's authors also list the limitations: how the PRP was prepared, the treatment procedure and the outcomes measured varied from study to study, none of the studies used a uniform assessment tool or trichoscopy (magnified examination of the scalp and hair), follow-up ranged from 8 weeks to 6 months, and with so few studies, a meta-analysis, meaning a pooled statistical analysis, can't be done.8 The Indian guideline recommends PRP as an adjunct in treating hair loss, not as a standalone or first-choice treatment. On its use during surgery, it states that small studies so far have described less post-operative hair loss and earlier growth of the transplanted hair, but this still needs confirming with properly controlled studies.2 What you can take from this: today, three small studies stand behind the benefit of PRP alongside a transplant. If it's offered to you, ask what method it's prepared with, and how much it costs.

I couldn't find a study on this. I looked for a clinical study that looked specifically at microneedling, meaning pricking the scalp with tiny needles, after hair transplantation, on the transplanted area, or at the survival of transplanted follicles, and I found none. I sell Dermastamp, an at-home microneedling device; I have nothing to say about a post-transplant effect, because there's no measurement of it.

Balwi and Koldas' 2026 review describes the practice as generally avoiding microneedling right after surgery, and later possibly building it in mainly on non-transplanted or thinning areas; according to them, protocols tailored to transplantation still need to be studied.9 The Indian guideline gives no rule on this, so when and where in your case is for your surgeon to decide. What you can take from this: if you're planning microneedling after a transplant, ask your surgeon before you go near the transplanted area.

I've written up finasteride's side effects and their frequency from the official label in a separate article. Following the European Medicines Agency's (EMA) 2025 EU-wide review, the Hungarian authority (NNGYK) and the manufacturers informed doctors by letter: suicidal ideation is a side effect linked to 1 mg daily finasteride, with an unknown frequency. Across all forms and indications of finasteride combined, the review identified 313 cases related to suicidal ideation in the European side-effect database, against an estimated exposure of roughly 270 million patient-years. Most of the cases were reported in patients treated for hair loss, ten times fewer in those treated for benign prostate enlargement. The letter asks doctors to tell patients: if you notice low mood, depression or suicidal thoughts, stop the treatment and see a doctor.10

If someone stops finasteride after surgery, according to Propecia's, the 1 mg daily tablet's, summary of product characteristics, the beneficial effect starts to reverse by month 6, and returns to baseline within 9 to 12 months.4 The label doesn't speak specifically about transplant patients; the details are in the article on stopping finasteride. Whether shedding can increase at the start of treatment is covered in the article on initial shedding. Ask your doctor this: if I stopped the medication after surgery, what would happen to my own hair around the transplant?

These are worth going through at the pre-op consultation.

• Do I need medication after surgery so my own hair around the transplant doesn't keep thinning?
• If I'm using finasteride or minoxidil, what should I do with them before surgery, and when can I restart?
• When can any device, for example microneedling, touch the transplanted area?
• Do you recommend PRP, what method is it prepared with, and how much does it cost?
• How do we track what happens to my own hair in the year after surgery?

Finasteride also comes in a form sprayed onto the scalp, covered in the article on topical finasteride.

There's no data on Dermastamp after a transplant. The fresh transplant area and the post-operative period are your surgeon's call; according to Balwi and Koldas' 2026 review, microneedling is generally avoided right after surgery.9 What follows is about microneedling in general, not about a transplanted scalp.

Microneedling is a mechanical stimulus with no hormonal effect, so it can be used alongside medications that act on DHT. Dermastamp is a fixed 1 mm, at-home device: the needle stimulates the area around the follicle, and its mechanism doesn't touch DHT. This is inferred from the mechanism, not measured. You don't skip oral finasteride or dutasteride on the day of stamping. With scalp-applied products, the day of stamping is a pause, and the exact timing differs by product: the timing of actives. A limitation of the data on hair loss is that in the study measuring the combination, both groups also received minoxidil, and the study used a 1.5 mm clinical roller, not our fixed 1 mm device; there's less data for standalone use. What it can do, what it can't, and who it's not for: I've written it all on its page.

See Dermastamp